Studying Neurons Using Glypromate

Trial Profile

Studying Neurons Using Glypromate

Phase of Trial: Phase II

Latest Information Update: 01 May 2006

At a glance

  • Drugs Glycine-proline-glutamate (Primary)
  • Indications Cognition disorders
  • Focus Adverse reactions; Pharmacokinetics; Registrational
  • Acronyms SNUG
  • Sponsors Neuren Pharmaceuticals
  • Most Recent Events

    • 01 May 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top